Measuring changes in substrate utilization in the myocardium in response to fasting using hyperpolarized [1-13C]butyrate and [1-13C]pyruvate
Cardiac dysfunction is often associated with a shift in substrate preference for ATP production. Hyperpolarized (HP) 13 C magnetic resonance spectroscopy (MRS) has the unique ability to detect real-time metabolic changes in vivo due to its high sensitivity and specificity. Here a protocol using HP [...
Saved in:
Published in | Scientific reports Vol. 6; no. 1; p. 25573 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
06.05.2016
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 2045-2322 2045-2322 |
DOI | 10.1038/srep25573 |
Cover
Summary: | Cardiac dysfunction is often associated with a shift in substrate preference for ATP production. Hyperpolarized (HP)
13
C magnetic resonance spectroscopy (MRS) has the unique ability to detect real-time metabolic changes
in vivo
due to its high sensitivity and specificity. Here a protocol using HP [1-
13
C]pyruvate and [1-
13
C]butyrate is used to measure carbohydrate versus fatty acid metabolism
in vivo
. Metabolic changes in fed and fasted Sprague Dawley rats (n = 36) were studied at 9.4 T after tail vein injections. Pyruvate and butyrate competed for acetyl-CoA production, as evidenced by significant changes in [
13
C]bicarbonate (−48%), [1-
13
C]acetylcarnitine (+113%) and [5-
13
C]glutamate (−63%), following fasting. Butyrate uptake was unaffected by fasting, as indicated by [1-
13
C]butyrylcarnitine. Mitochondrial pseudoketogenesis facilitated the labeling of the ketone bodies [1-
13
C]acetoacetate and [1-
13
C]β-hydroxybutyryate, without evidence of true ketogenesis. HP [1-
13
C]acetoacetate was increased in fasting (250%) but decreased during pyruvate co-injection (−82%). Combining HP
13
C technology and co-administration of separate imaging agents enables noninvasive and simultaneous monitoring of both fatty acid and carbohydrate oxidation. This protocol illustrates a novel method for assessing metabolic flux through different enzymatic pathways simultaneously and enables mechanistic studies of the changing myocardial energetics often associated with disease. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/srep25573 |